The FDA is warning patients about “counterfeit” Ozempic. Drug manufacturer Novo Nordisk seized “several hundred units” from ...

GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...

"GLP-1 medications are currently the most effective weight loss adjunct available if the patient does not meet the criteria ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Eli Lilly Takes on Novo Nordisk with Orforglipron, an Oral Drug for Diabetes and Obesity That Could Change the Market. FDA ...

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Novo Nordisk (NYSE:NVO) shares sank more than 7% in Copenhagen after Eli Lilly (NYSE:LLY) released promising trial results for its experimental obesity pill, orforglipron, which showed weight loss and ...